SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950116-05-001301
Filing Date
2005-04-07
Accepted
2005-04-07 14:47:11
Documents
1
Period of Report
2005-04-05

Document Format Files

Seq Description Document Type Size
1 FORM_4.XML p405890_ex.html 4  
1 FORM_4.XML p405890_ex.xml 4 3552
  Complete submission text file 0000950116-05-001301.txt   5326
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1258 RAVINE DRIVE MISSIISSAUGA ONARTIO A1 L5J3E4
Business Address
BARRATT JOHN P (Reporting) CIK: 0001270529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 05739070